NASDAQ: MEDSDatameds Ai Inc Stock Ownership - Who owns Datameds Ai?
Insider buying vs selling
Have Datameds Ai Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Surendra K. Ajjarapu | Director | 2026-06-22 | 100,000 | $0.01 | $500.00Buy |
| Prashant Patel | Chief Executive Officer | 2026-06-22 | 100,000 | $0.01 | $500.00Buy |
| Surendra K. Ajjarapu | Director | 2026-03-31 | 5,000,000 | $0.20 | $1.00MBuy |
| Surendra K. Ajjarapu | Director | 2026-03-31 | 5,000,000 | $0.20 | $1.00MBuy |
| Prashant Patel | Chief Executive Officer | 2026-03-31 | 5,000,000 | $0.20 | $1.00MBuy |
| Prashant Patel | Chief Executive Officer | 2026-03-31 | 5,000,000 | $0.20 | $1.00MBuy |
MEDS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MEDS insiders and whales buy or sell their stock.
MEDS Shareholders
What type of owners hold Datameds Ai Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Brian Norton | 721.33% | 11,524,308 | $10.56M | Insider |
| Prashant Patel | 585.51% | 9,354,365 | $8.57M | Insider |
| Surendra K. Ajjarapu | 489.52% | 7,820,845 | $7.16M | Insider |
| Nikul Panchal | 23.52% | 375,761 | $344.20k | Insider |
| Srinivas Kalla | 18.36% | 293,333 | $268.69k | Insider |
| Donald William Anderson | 15.32% | 244,720 | $224.16k | Insider |
| Rebecca M. Shanahan | 15.32% | 244,720 | $224.16k | Insider |
| Sajid Syed | 15.32% | 244,720 | $224.16k | Insider |
| Michael L. Peterson | 12.52% | 200,000 | $183.20k | Insider |
| Shafaat Pirani | 6.39% | 102,080 | $93.51k | Insider |
MEDS vs Pharmaceutical Retailer Stocks
Datameds Ai Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.